President Joe Biden will speak at the Eisenhower Executive Building in Washington, DC, USA on Monday, March 29, 2021.
Stephanie Reynolds | Bloomberg | Getty Images
The Byden administration announced Thursday that the United States has invested $ 3.2 billion to advance the development of antiviral drugs to treat potentially pandemic Covid-19 and other viruses.
A new program, called the Antiviral Program for Pandemics, is a “government-wide effort to speed up clinical trials of promising candidate drugs and develop next-generation treatments for Covid and other viruses that may cause future pandemics. “is. Chief Medical Advisor Dr. Anthony Fauci said at a press conference.
As part of the plan, the National Institutes of Health will “evaluate, prioritize, and advance” antiviral drug candidates, conduct Phase 2 clinical trials, and “develop candidates,” according to another announcement from the government. I will guide you along the path. “
The vaccine continues to be the “eyeball” of the US arsenal against Covid, who is also the director of the National Institute of Allergy and Infectious Diseases, he told reporters at a White House briefing. Coronavirus pandemic.. “Antiviral drugs are an important complement to existing vaccines, especially for people with certain conditions that may be at greater risk,” he added. I did.
Vaccines are very effective in reducing infections in the United States, but officials say more treatment is needed for those who are infected with the virus or whose immune system does not respond well to the vaccine.
Many treatments for Covid are under development and may be distributed in the United States by the end of the year. Pfizer, For example Started in March Early-stage clinical trials testing experimental oral medications to treat Covid with the first signs of illness.
This drug is part of a class of drugs called protease inhibitors that work by blocking enzymes that the virus needs to replicate in human cells. Protease inhibitors are used to treat other viral pathogens such as HIV and hepatitis C.
The Byden administration’s plans provide more than $ 300 million for research and laboratory support, nearly $ 1 billion for preclinical and clinical evaluation, and nearly $ 700 million for development and manufacturing by NIAID and the Biomedical Advanced Research and Development Agency. I will.
In addition, the plan has allocated up to $ 1.2 billion to support the creation of drug discovery groups targeting coronavirus and other viruses.
“The remarkable rapid development of vaccines and testing technology shows how agile scientific discoveries can be combined with public institutions, private sectors, and the best and most creative spiritual resources in the United States.” Said Dr. Francis S. Collins, Director of NIH. Said in a statement.
“We have these same strengths in building a platform for the discovery and development of effective antivirals that will help defeat COVID-19 and prepare for potential future viral pathogens. I’ll take advantage of it, “he added.
Biden administration spends $ 3.2 billion on Covid’s antivirals
Source link Biden administration spends $ 3.2 billion on Covid’s antivirals